4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-21-025331
Director sold 6,000 shares at $15.35 ($92,100)
- Director acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| LEE KENNETH B JR Director | 2021-09-13 | Option exercise | +15,000 | $3.22 | $48,300 | 30,252 | D |
| LEE KENNETH B JR Director | 2021-09-13 | Sale | −6,000 | $15.35 | $92,100 | 24,252 | D |
| Derivatives | |||||||
| LEE KENNETH B JR Director | 2021-09-13 | Option exercise · Automatic Stock Option Grant | −15,000 | 0 | D | ||
| Open-market sales · 6,000 sh · avg $15.35 · $92,100 | |||||||
Loading xslF345X03/form4.xml…